G

Genincode PLC
LSE:GENI

Watchlist Manager
Genincode PLC
LSE:GENI
Watchlist
Price: 2.85 GBX -16.18% Market Closed
Market Cap: 8.2m GBX
Section:
 

Relative Value

GENI price has not been updated for more than 1 year. This may indicate that the stock has been delisted.
GENI doesn't have a meaningful market cap.

The Relative Value of one GENI stock under the Base Case scenario is hidden GBX. Compared to the current market price of 2.85 GBX, Genincode PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GENI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

2.8
P/S
P/S
Price to Sales
2.8
vs History
54
vs Industry
36
Median 3Y
3.4
Median 5Y
3.5
Industry
2.3
Forward
2.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1.9
Industry
22.5
Forward
-1.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-1.9
Industry
14.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-1.9
Industry
21.5
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
30
vs Industry
29
Median 3Y
2.6
Median 5Y
2.4
Industry
2.2
More Details
2
EV/S
EV/S
Enterprise Value to Sales
2
vs History
40
vs Industry
46
Median 3Y
2.1
Median 5Y
2.2
Industry
2.6
Forward
1.8
More Details
3.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.8
vs History
45
vs Industry
48
Median 3Y
4
Median 5Y
4.4
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
57
Median 3Y
-0.8
Median 5Y
-0.9
Industry
11.9
Forward
-1.4
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
53
Median 3Y
-0.8
Median 5Y
-0.9
Industry
16.9
Forward
-1.3
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
59
Median 3Y
-0.8
Median 5Y
-1
Industry
14.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
48
Median 3Y
-0.8
Median 5Y
-1
Industry
18.7
More Details
16.4
EV/IC
EV/IC
Enterprise Value to IC
16.4
vs History
21
vs Industry
5
Median 3Y
6.8
Median 5Y
4.4
Industry
1.9
More Details

Multiples Across Competitors

GENI Competitors Multiples
Genincode PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Genincode PLC
LSE:GENI
8.2m GBP 2.8 -1.6 -1.2 -1.1
US
CVS Health Corp
NYSE:CVS
100.1B USD 0.3 213.1 14 14
US
Cigna Corp
NYSE:CI
70.3B USD 0.3 11.5 7.4 9.5
US
Cigna Group
XMUN:CGN
60.6B EUR 0.3 11.5 7.5 9.5
DE
Fresenius SE & Co KGaA
XETRA:FRE
26.4B EUR 1.2 23.1 10.2 15.4
DE
Fresenius Medical Care AG
XMUN:FME
23.4B EUR 1.2 32.6 10.3 21.9
US
Laboratory Corporation of America Holdings
NYSE:LH
21.4B USD 1.6 25.1 13.6 19
US
Quest Diagnostics Inc
NYSE:DGX
19.9B USD 1.8 20.7 11.4 15.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.4B EUR 0.6 15.9 6.3 13.5
US
Guardant Health Inc
NASDAQ:GH
12.8B USD 14.3 -32.3 -33.8 -30.7
US
Hims & Hers Health Inc
NYSE:HIMS
9B USD 4 66.6 53.4 70.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
G
Genincode PLC
LSE:GENI
Average EV/EBITDA: 14.9
Negative Multiple: -1.2 		N/A N/A
US
CVS Health Corp
NYSE:CVS
14
25%
0.6
US
Cigna Corp
NYSE:CI
7.4
4%
1.9
US
C
Cigna Group
XMUN:CGN
7.5
4%
1.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.2
14%
0.7
DE
Fresenius Medical Care AG
XMUN:FME
10.3
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
13.6
16%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
11.4
8%
1.4
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.3
10%
0.6
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -33.8 N/A N/A
US
Hims & Hers Health Inc
NYSE:HIMS
53.4
79%
0.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
G
Genincode PLC
LSE:GENI
Average EV/EBIT: 21
Negative Multiple: -1.1 		N/A N/A
US
CVS Health Corp
NYSE:CVS
14
18%
0.8
US
Cigna Corp
NYSE:CI
9.5
4%
2.4
US
C
Cigna Group
XMUN:CGN
9.5
4%
2.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.4
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
21.9
25%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
19
27%
0.7
US
Quest Diagnostics Inc
NYSE:DGX
15.5
11%
1.4
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.5
25%
0.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -30.7 N/A N/A
US
Hims & Hers Health Inc
NYSE:HIMS
70.6
49%
1.4

See Also

Summary
GENI intrinsic value, competitors valuation, and company profile.
DCF Valuation
GENI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GENI stock valuation using valuation multiples.
Wall Street Estimates
GENI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GENI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 301,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.